BMI history and risk of incident fatty liver: A population-based large-scale cohort study

European Journal of Gastroenterology and Hepatology

Volumn 28, Issue 10, 2016, Pages 1188-1193

  Hashimoto, Yoshitak ^a   Hamaguchi, Masahide ^b   Fukuda, Takuya ^a   Nakamura, Naoto ^a   Ohbora, Akihiro ^c   Kojima, Takao ^c   Fukui, Michiaki ^a  

^a KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^b Kameoka Municipal Hospital   (Japan)

^c ASAHI UNIVERSITY   (Japan)

Author keywords

BMI; epidemiology; metabolic syndrome; nonalcoholic fatty liver disease; weight gain

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; GAMMA GLUTAMYLTRANSFERASE; GLUCOSE; HEPATITIS B ANTIGEN; HEPATITIS C ANTIBODY; TRIACYLGLYCEROL; URIC ACID;

ABDOMINAL RADIOGRAPHY; ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BODY MASS; COHORT ANALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DIASTOLIC BLOOD PRESSURE; FATTY LIVER; FEMALE; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; GLUCOSE BLOOD LEVEL; HUMAN; INCIDENCE; JAPANESE (PEOPLE); LARGE SCALE PRODUCTION; LIFESPAN; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; OBSERVATIONAL STUDY; PERIODIC MEDICAL EXAMINATION; POPULATION BASED CASE CONTROL STUDY; PRIORITY JOURNAL; STANDARD; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; ULTRASOUND SCANNER; URIC ACID BLOOD LEVEL; AREA UNDER THE CURVE; CHI SQUARE DISTRIBUTION; DIAGNOSTIC IMAGING; ECHOGRAPHY; JAPAN; MIDDLE AGED; OBESITY; ODDS RATIO; PREDICTIVE VALUE; RECEIVER OPERATING CHARACTERISTIC; RISK ASSESSMENT; RISK FACTOR; STATISTICAL MODEL; TIME FACTOR;

ADULT; AREA UNDER CURVE; BODY MASS INDEX; CHI-SQUARE DISTRIBUTION; FATTY LIVER; FEMALE; HUMANS; INCIDENCE; JAPAN; LOGISTIC MODELS; MALE; MIDDLE AGED; OBESITY; ODDS RATIO; PREDICTIVE VALUE OF TESTS; RISK ASSESSMENT; RISK FACTORS; ROC CURVE; TIME FACTORS; ULTRASONOGRAPHY;

EID: 84976288663     PISSN: 0954691X     EISSN: 14735687     Source Type: Journal    
DOI: 10.1097/MEG.0000000000000682     Document Type: Article

References (38)

1. Neuschwander-Tetri BA, Caldwell SH. Nonalcoholic steatohepatitis: Summary of an AASLD Single Topic Conference. Hepatology 2003; 37:1202-1219.
2. Angulo P. Nonalcoholic fatty liver disease. N Engl J Med 2002; 346:1221-1231.
3. Adams LA, Waters OR, Knuiman MW, Elliott RR, Olynyk JK. NAFLD as a risk factor for the development of diabetes and the metabolic syndrome: An eleven-year follow-up study. Am J Gastroenterol 2009; 104:861-867.
4. Fukuda T, Hamaguchi M, Kojima T, Hashimoto Y, Ohbora A, Kato T, et al. The impact of non-alcoholic fatty liver disease on incident type 2 diabetes mellitus in non-overweight individuals. Liver Int 2016; 36:275-283.
5. Musso G, Gambino R, Tabibian JH, Ekstedt M, Kechagias S, Hamaguchi M, et al. Association of non-alcoholic fatty liver disease with chronic kidney disease: A systematic review and meta-analysis. PLoS Med 2014; 11:e1001680.
6. Hamaguchi M, Kojima T, Takeda N, Nagata C, Takeda J, Sarui H, et al. Nonalcoholic fatty liver disease is a novel predictor of cardiovascular disease. World J Gastroenterol 2007; 13:1579-1584.
7. Hashimoto Y, Hamaguchi M, Kojima T, Ohshima Y, Ohbora A, Kato T, et al. The modest alcohol consumption reduces the incidence of fatty liver in men; a population based large scale cohort study. J Gastroenterol Hepatol 2015; 30:546-552.
8. Moriya A, Iwasaki Y, Ohguchi S, Kayashima E, Mitsumune T, Taniguchi H, et al. Roles of alcohol consumption in fatty liver: A longitudinal study. J Hepatol 2015; 62:921-927.
9. Speliotes EK, Massaro JM, Hoffmann U, Vasan RS, Meigs JB, Sahani DV, et al. Fatty liver is associated with dyslipidemia and dysglycemia independent of visceral fat: The Framingham Heart Study. Hepatology 2010; 51:1979-1987.
10. Finucane MM, Stevens GA, Cowan MJ, Danaei G, Lin JK, Paciorek CJ, et al. National, regional, and global trends in body-mass index since 1980: Systematic analysis of health examination surveys and epidemiological studies with 960 country-years and 9'1 million participants. Lancet 2011; 377:557-567.
11. Hamaguchi M, Kojima T, Takeda N, Nakagawa T, Taniguchi H, Fujii K, et al. The metabolic syndrome as a predictor of nonalcoholic fatty liver disease. Ann Intern Med 2005; 143:722-728.
12. Yoshizawa S, Heianza Y, Arase Y, Saito K, Hsieh SD, Tsuji H, et al. Comparison of different aspects of BMI history to identify undiagnosed diabetes in Japanese men and women: Toranomon Hospital Health Management Center Study 12 (TOPICS 12). Diabet Med 2014; 31:1378-1386.
13. Nanri A, Mizoue T, Takahashi Y, Matsushita Y, Noda M, Inoue M, et al. Association of weight change in different periods of adulthood with risk of type 2 diabetes in Japanese men and women: The Japan Public Health Center-Based Prospective Study. J Epidemiol Community Health 2011; 65:1104-1110.
14. Shihab HM, Meoni LA, Chu AY, Wang NY, Ford DE, Liang KY, et al. Body mass index and risk of incident hypertension over the life course: The Johns Hopkins Precursors Study. Circulation 2012; 126:2983-2989.
15. Wakasugi M, Narita I, Iseki K, Moriyama T, Yamagata K, Tsuruya K, et al. Weight gain after 20 years of age is associated with prevalence of chronic kidney disease. Clin Exp Nephrol 2012; 16:259-268.
16. Chei CL, Iso H, Yamagishi K, Inoue M, Tsugane S. Body mass index and weight change since 20 years of age and risk of coronary heart disease among Japanese: The Japan Public Health Center- Based Study. Int J Obes (Lond) 2008; 32:144-151.
17. McCullough AJ. The clinical features, diagnosis and natural history of nonalcoholic fatty liver disease. Clin Liver Dis 2004; 8:521-533.
18. Fukuda Y, Hashimoto Y, Hamaguchi M, Fukuda T, Nakamura N, Ohbora A, et al. Triglycerides to high-density lipoprotein cholesterol ratio is an independent predictor of incident fatty liver; a population-based cohort study. Liver Int 2015; 36:713-720.
19. Hamaguchi M, Kojima T, Ohbora A, Takeda N, Fukui M, Kato T. Protective effect of alcohol consumption for fatty liver but not metabolic syndrome. World J Gastroenterol 2012; 18:156-167.
20. Aaron DJ, Kriska AM, Dearwater SR, Cauley JA, Metz KF, LaPorte RE. Reproducibility and validity of an epidemiologic questionnaire to assess past year physical activity in adolescents. Am J Epidemiol 1995; 142:191-201.
21. Ryu S, Chang Y, Kim DI, Kim WS, Suh BS. gamma-Glutamyltransferase as a predictor of chronic kidney disease in nonhypertensive and nondiabetic Korean men. Clin Chem 2007; 53:71-77.
22. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2010; 33 (Suppl 1):S62-S69.
23. Hamaguchi M, Kojima T, Itoh Y, Harano Y, Fujii K, Nakajima T, et al. The severity of ultrasonographic findings in nonalcoholic fatty liver disease reflects the metabolic syndrome and visceral fat accumulation. Am J Gastroenterol 2007; 102:2708-2715.
24. Kimura T, Deshpande GA, Urayama KY, Masuda K, Fukui T, Matsuyama Y. Weight gain since age 20 is associated with nonalcoholic fatty liver disease in normal weight individuals. J Gastroenterol Hepatol 2015; 30:909-917.
25. Byrne CD. Ectopic fat, insulin resistance and non-alcoholic fatty liver disease. Proc Nutr Soc 2013; 72:412-419.
26. Adiels M, Westerbacka J, Soro-Paavonen A, Häkkinen AM, Vehkavaara S, Caslake MJ, et al. Acute suppression of VLDL1 secretion rate by insulin is associated with hepatic fat content and insulin resistance. Diabetologia 2007; 50:2356-2365.
27. Kim JY, van de Wall E, Laplante M, Azzara A, Trujillo ME, Hofmann SM, et al. Obesity-associated improvements in metabolic profile through expansion of adipose tissue. J Clin Invest 2007; 117:2621-2637.
28. Spalding KL, Arner E, Westermark PO, Bernard S, Buchholz BA, Bergmann O, et al. Dynamics of fat cell turnover in humans. Nature 2008; 453:783-787.
29. Virtue S, Vidal-Puig A. It's not how fat you are, it's what you do with it that counts. PLoS Biol 2008; 6:e237.
30. Kohara K. Sarcopenic obesity in aging population: Current status and future directions for research. Endocrine 2014; 45:15-25.
31. Newman AB, Kupelian V, Visser M, Simonsick E, Goodpaster B, Nevitt M, et al. Sarcopenia: Alternative definitions and associations with lower extremity function. J Am Geriatr Soc 2003; 51:1602-1609.
32. Hughes VA, Frontera WR, Roubenoff R, Evans WJ, Singh MAF. Longitudinal changes in body composition in older men and women: Role of body weight change and physical activity. Am J Clin Nutr 2002; 76:473-481.
33. Hong HC, Hwang SY, Choi HY, Yoo HJ, Seo JA, Kim SG, et al. Relationship between sarcopenia and nonalcoholic fatty liver disease: The Korean Sarcopenic Obesity Study. Hepatology 2014; 59:1772-1778.
34. Vernon G, Baranova A, Younossi ZM. Systematic review: The epidemiology and natural history of non-alcoholic fatty liver disease and nonalcoholic steatohepatitis in adults. Aliment Pharmacol Ther 2011; 34:274-285.
35. Armstrong MJ, Houlihan DD, Bentham L, Shaw JC, Cramb R, Olliff S, et al. Presence and severity of non-alcoholic fatty liver disease in a large prospective primary care cohort. J Hepatol 2012; 56:234-240.
36. Sumida Y, Yoneda M, Hyogo H, Itoh Y, Ono M, Fujii H, et al. Validation of the FIB4 index in a Japanese nonalcoholic fatty liver disease population. BMC Gastroenterol 2012; 12:2.
37. Hernaez R, Lazo M, Bonekamp S, Kamel I, Brancati FL, Guallar E, et al. Diagnostic accuracy and reliability of ultrasonography for the detection of fatty liver: A meta-analysis. Hepatology 2011; 54:1082-1090.
38. Casey VA, Dwyer JT, Berkey CS, Coleman KA, Gardner J, Valadian I. Long-term memory of body weight and past weight satisfaction: A longitudinal follow-up study. Am J Clin Nutr 1991; 53:1493-1498.